EPFL spin-off MoleSense has received €156,000 from Venture Kick to develop molecular wearables for continuous, non-invasive monitoring of biochemical markers in high-risk pregnancies, aiming to provide real-time insights for early diagnosis and targeted interventions.
MoleSense Secures €156K to Pioneer Molecular Wearables in Maternity Care
October 28, 2025